Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
QMS Medical Allied ServicesNSE:QMSMEDI -1.06%77 3-Year ROIIC % is 9.01 as of Mar. 2026, which is 244% above its 10-year median of 2.62. GuruFocus rates NSE:QMSMEDI with a GF Score™ of 77/100 and a GF Value™ of ₹121.05 (Fairly Valued). The stock has 7 warning signs investors should review. Among 795 Medical Devices & Instruments companies, QMS Medical Allied Services ranks better than 59.75% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
QMS Medical Allied Services's 3-Year ROIIC % for the quarter that ended in Mar. 2026 was 9.01%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for QMS Medical Allied Services's 3-Year ROIIC % or its related term are showing as below:
NSE:QMSMEDI's 3-Year ROIIC % is ranked better than 59.75% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 1.47
vs NSE:QMSMEDI: 9.01
QMS Medical Allied Services (NSE:QMSMEDI) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
QMS Medical Allied Services 3-Year ROIIC % Related Terms
QMS Medical Allied Services 3-Year ROIIC % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:QMSMEDI vs ISRG, BDX, MDLN: 3-Year ROIIC % Comparison
For the Medical Instruments & Supplies subindustry, QMS Medical Allied Services's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
QMS Medical Allied Services 3-Year ROIIC % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, QMS Medical Allied Services's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where QMS Medical Allied Services's 3-Year ROIIC % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
QMS Medical Allied Services (NSE:QMSMEDI) has a 3-Year ROIIC % of 9.01 as of Mar. 2026. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on QMS Medical Allied Services and its competitors. This is 244% above median its historical median of 2.62. According to the industry distribution chart, QMS Medical Allied Services ranks #320 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 40.3%.
Is QMS Medical Allied Services' 3-Year ROIIC % too high?
QMS Medical Allied Services' current 3-Year ROIIC % of 9.01 is 244% above median its 10-year median of 2.62. The Medical Devices & Instruments industry median 3-Year ROIIC % is 1.47. QMS Medical Allied Services' value of 9.01 is 512.9% above this industry median. Based on the distribution chart, QMS Medical Allied Services ranks #320 out of 795 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, QMS Medical Allied Services has a GF Score™ of 77/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does QMS Medical Allied Services' 3-Year ROIIC % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, QMS Medical Allied Services ranks #320 out of 795 companies for 3-Year ROIIC %. This puts QMS Medical Allied Services in the upper half of its industry. The industry median 3-Year ROIIC % is 1.47. QMS Medical Allied Services' value of 9.01 is 512.9% above this benchmark. While the company's 10-year median is 2.62 vs. the industry median of 1.47, QMS Medical Allied Services has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Medical Devices & Instruments company?
The median 3-Year ROIIC % among Medical Devices & Instruments companies is 1.47, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. QMS Medical Allied Services's current 3-Year ROIIC % of 9.01 is 512.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on QMS Medical Allied Services and its competitors. For the Medical Devices & Instruments industry, the median 3-Year ROIIC % is 1.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. QMS Medical Allied Services's current 3-Year ROIIC % is 9.01, which is 244% above median its own 10-year median of 2.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is QMS Medical Allied Services stock overvalued right now?
Based on GuruFocus' analysis, QMS Medical Allied Services (NSE:QMSMEDI) is currently considered Fairly Valued. The stock's GF Value™ is ₹121.05, compared to a current price of ₹113.30 — trading 6.4% below its estimated fair value. The current 3-Year ROIIC % is 9.01, which is 244% above median its 10-year median of 2.62 and 512.9% above the Medical Devices & Instruments industry median of 1.47. QMS Medical Allied Services' overall GF Score™ is 77/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For QMS Medical Allied Services (NSE:QMSMEDI), the current 3-Year ROIIC % is 9.01 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is QMS Medical Allied Services (NSE:QMSMEDI) Overvalued in 2026?
Based on GuruFocus' analysis, QMS Medical Allied Services stock appears to be undervalued.
The current stock price of ₹113.30 is trading 6.4% below its estimated GF Value™ of ₹121.05.
GuruFocus considers QMS Medical Allied Services to be Fairly Valued.
Key valuation signals for NSE:QMSMEDI:
3-Year ROIIC %: 9.01 (244% above median its 10-year median of 2.62)
GF Value™: ₹121.05 vs. price of ₹113.30 (6.4% below fair value)
Industry Position: 512.9% above the Medical Devices & Instruments median (#320 of 795)
No single metric tells the full story. See the NSE:QMSMEDI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
QMS Medical Allied Services Ltd is engaged in the marketing and distribution of a wide range of medical products as well as medical education services. The company's products are sold under brand name "QDevices" and also manage the distribution for other brands such as 3M, Heine, Rossmax and others. It offers medical products such as Blood Pressure Monitors, Glucose Monitoring Kits and strips, Dental Products, Personal protection kits eg-PPE kits, Infection prevention, Stethoscope and Oxygen Concentrator.
77GF Score
Get the complete analysis for NSE:QMSMEDI
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:QMSMEDI has been successfully added to your 
